Industry Symposium 3

29 Mar 2026 8:10 a.m. 9:10 a.m.
304
AkiraNishiyama Chair Japan
MarikoMiyazaki Chair Japan

Session Title: Uric Acid and Kidney Disease
Organized by: MOCHIDA PHARMACEUTICAL CO.,LTD.

Session Description:
Elevated serum uric acid levels in the general population are associated with the onset of chronic kidney disease. In patients with chronic kidney disease, elevated serum uric acid levels are associated with the progression of renal impairment. In Japan, dotinurad, a selective uric acid reabsorption inhibitor, is available for use. Its efficacy is attracting attention as it does not affect other uric acid transporters.

Learning Objectives:
This seminar will provide an overview from two experts, incorporating their own case studies, on the relationship between uric acid and renal impairment, its physiology and pathophysiology, as well as the classification of hyperuricaemia subtypes and the types and selection of urate-lowering drugs.

Time Session
8:10 a.m.
8:40 a.m.
YOSHITAKAISAKA Speaker isaka@kid.med.osaka-u.ac.jpJapan
8:40 a.m.
9:10 a.m.
JunWada Speaker junwada@okayama-u.ac.jpJapan